ReviewThe Lancet. Oncology2020

Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions.

Charles L Bennett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.